When Daniel was diagnosed with a brain tumor near his brain stem, he was about to turn two. His symptoms started small, a head tilt so slight that only his doctor caught it. Then, at daycare, he suffered a seizure-like episode where he couldn’t focus on anyone in the room. That was the moment everything changed.
The diagnosis was a brain tumor sitting in one of the most difficult locations possible. The tumor lay right next to the brain stem, where surgeons couldn’t safely remove it. Doctors tried to remove as much as possible, but it grew back to the same size within three months. A second surgery proved fruitless, as well. Daniel’s family made the difficult decision to start a two-year chemotherapy regimen, which he completed a year and a half ago.
This is where CURE’s funding of precision medicine changed the course of Daniel’s story. Genetic testing of his tumor answered two critical questions: it confirmed the tumor wasn’t a type prone to spreading through the spinal cord, and it revealed a mutation in the BRAF gene.
That discovery opened the door to a clinical trial of a drug originally approved a decade ago for adult melanoma patients with the same mutation. It has since become a turning point in pediatric treatment, offering new options for kids like Daniel. Out of all the options, it was the one his family and doctors believed would work best with the least impact on his daily life. They were right. Daniel has thrived on the trial.
“He is doing so well that you’d never guess he is undergoing any type of treatment,” shared his mother, Anna.
Daniel’s tumor will always be part of his life. It can’t be removed, and the goal now is to keep it dormant for good. But his childhood hasn’t been defined by that fight. He’s eight, very active, and obsessed with baseball. He loves to play the sport or watch just about any game on TV.
Precision medicine didn’t just give Daniel’s family a treatment plan. It gave them clarity in the middle of the scariest uncertainty imaginable, and it gave Daniel back his childhood.
As we head toward Childhood Cancer Awareness Month, Daniel’s story is exactly why CURE exists: to turn research into full childhoods like his.
